| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Co-founder | CEO | Director +1 more
3 companies
Marlett Christopher A is a Director, 10% Owner at Arena Group Holdings, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 18 buys and 0 sells.
Estimated insider holdings value: $35.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 19,647 | $4.29 | $84,285.63 | +38.2% | |
| Dec 21, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 17,200 | $4.53 | $77,916.00 | +50.2% | |
| Dec 20, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 9,438 | $4.74 | $44,736.12 | +38.1% | |
| Dec 19, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 400 | $5.00 | $2,000.00 | +1.6% | |
| Dec 18, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 3,664 | $5.20 | $19,052.80 | +17.7% | |
| Dec 13, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 10,000 | $5.06 | $50,600.00 | +93.2% | |
| Dec 12, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 12,189 | $5.08 | $61,978.23 | +161.6% | |
| Dec 11, 2018 | CUE Cue Biopharma, Inc. | Director | Buy | 7,543 | $4.86 | $36,658.98 | New | |
| Dec 5, 2017 | AREN Arena Group Holdings, Inc. | Director, 10% Owner | Buy | 30,830 | $1.42 | $43,850.50 | +0.2% | |
| Dec 4, 2017 | AREN Arena Group Holdings, Inc. | Director, 10% Owner | Buy | 33,825 | $1.52 | $51,356.00 | +0.3% |